International Aesthetic Biotech

International Aesthetic Biotech (IAB) is a biotechnology company specializing in the development and commercialization of advanced medical aesthetic products. The company focuses on high-quality dermal fillers, botulinum toxins, and skin boosters designed for minimally invasive cosmetic procedures. IAB leverages proprietary cross-linking technologies to enhance the longevity and safety profiles of its hyaluronic acid-based products. Their portfolio serves a global market, providing clinicians with tools for facial contouring, wrinkle reduction, and skin revitalization. By integrating research and development with manufacturing, IAB aims to deliver innovative solutions that meet the evolving demands of the aesthetic medicine industry.